1-14 of 14
Wei Gong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4375: ALPPL2 is involved in MAPK signal pathway of pancreatic cancer

Ke Wei Gong, Bilal Hamid, Kenny W. Castro, Martina S. McDermott, Forrest Epstein, Kevin Chau, Chuhong Hu, Jun Zhang, Ming Lu, Benjamin G. Hoffstrom, Neil A. O'Brien, Dennis J. Slamon
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4375.
https://doi.org/10.1158/1538-7445.AM2024-4375
Published: 22 March 2024
View article titled, Abstract 4375: ALPPL2 is involved in MAPK signal pathway of pancreatic cancer
Journal Articles

Abstract 1900: TORL-3-600, a novel antibody drug conjugate directed against cadherin 17 (CDH17), has preclinical efficacy in colorectal, gastric, and pancreatic cancer

Neil A. O'Brien, Martina SJ McDermott, Jun Zhang, Ming Lu, Ke Wei Gong, Benjamin Hoffstrom, Wei Ping Jia, Tong Luo, Athena M. Madrid, Min Liang, John A. Glaspy, Dennis J. Slamon
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1900.
https://doi.org/10.1158/1538-7445.AM2024-1900
Published: 22 March 2024
View article titled, Abstract 1900: TORL-3-600, a novel antibody drug conjugate directed against cadherin 17 (CDH17), has preclinical efficacy in colorectal, gastric, and pancreatic cancer
Journal Articles

Abstract 342: Development and characterization of a novel anti-CLDN6 antibody drug conjugate for the treatment of CLDN6 positive cancers

Martina S. McDermott, Ke Wei Gong, Neil A. O'Brien, Dylan Conklin, Benjamin Hoffstrom, Ming Lu, Jun Zhang, Tong Luo, Weiping Jia, Jenny J. Hong, Kevin Chau, Simon Davenport, Michael F. Press, Abram Handly-Santana, Joan S. Brugge, Ronny Drapkin, John A. Glaspy, Leonard Presta, Dennis J. Slamon
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 342.
https://doi.org/10.1158/1538-7445.AM2022-342
Published: 15 June 2022
View article titled, Abstract 342: Development and characterization of a novel anti-CLDN6 antibody drug conjugate for the treatment of CLDN6 positive cancers
Journal Articles

Abstract LB197: Tucatinib has selective activity in HER2-positive cancers and significant combined activity with approved and novel breast cancer targeted therapies

Neil A. O'Brien, Holly K. Huang, Martina S. McDermott, Athena Madrid, Tong Luo, Raul Ayala, Shawnt Issakhanian, Ke Wei Gong, Ming Lu, Jun Zhang, Dennis J. Slamon
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): LB197.
https://doi.org/10.1158/1538-7445.AM2022-LB197
Published: 15 June 2022
View article titled, Abstract LB197: Tucatinib has selective activity in HER2-positive cancers and significant combined activity with approved and novel breast cancer targeted therapies
Journal Articles

Abstract 332: Development of a novel therapeutic CLDN18.2 monoclonal antibody and antibody drug conjugate for the treatment of CLDN18.2 positive cancers

Neil A. O'brien, Martina S. McDermott, Jun Zhang, Ke Wei Gong, Ming Lu, Benjamin G. Hoffstrom, Dylan Conklin, Tong Luo, Kevin Chau, Min Liang, Timothy R. Donahue, John A. Glaspy, Leonard Presta, Dennis J. Slamon
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 332.
https://doi.org/10.1158/1538-7445.AM2022-332
Published: 15 June 2022
View article titled, Abstract 332: Development of a novel therapeutic CLDN18.2 monoclonal antibody and antibody drug conjugate for the treatment of CLDN18.2 positive cancers
Journal Articles

Long Noncoding RNA GCASPC, a Target of miR-17-3p, Negatively Regulates Pyruvate Carboxylase–Dependent Cell Proliferation in Gallbladder Cancer

Ming-zhe Ma, Yan Zhang, Ming-zhe Weng, Shou-hua Wang, Ye Hu, Zhao-yuan Hou, Yi-yu Qin, Wei Gong, Yong-Jie Zhang, Xiang Kong, Jian-dong Wang, Zhi-wei Quan
Journal: Cancer Research
Series: Author Choice
Cancer Res (2016) 76 (18): 5361–5371.
https://doi.org/10.1158/0008-5472.CAN-15-3047
Published: 15 September 2016
View article titled, Long Noncoding RNA <em>GCASPC</em>, a Target of miR-17-3p, Negatively Regulates Pyruvate Carboxylase–Dependent Cell Proliferation in Gallbladder Cancer
Open the PDF for Long Noncoding RNA <em>GCASPC</em>, a Target of miR-17-3p, Negatively Regulates Pyruvate Carboxylase–Dependent Cell Proliferation in Gallbladder Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 454: Evaluating the progression of cutaneous melanoma by the molecular immune response of the sentinel lymph node

Richard Essner, Alexandra Gangi, David Kaufman, Ke Wei Gong, Myung Sim, Dennis Slamon
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 454.
https://doi.org/10.1158/1538-7445.AM2015-454
Published: 01 August 2015
View article titled, Abstract 454: Evaluating the progression of cutaneous melanoma by the molecular immune response of the sentinel lymph node
Journal Articles

Abstract A26: Protein phosphatase 4 (PP4) as a potential therapeutic target gene for BRAF wild type melanoma

Richard Essner, Ke Wei Gong, David Kaufman, Hsiaowang Chen, Charles Ginther, Judy Dering, Erika von Euw, Bartosz Chmielowski, Richard Finn, Dennis Slamon
Journal: Cancer Research
Cancer Res (2015) 75 (14_Supplement): A26.
https://doi.org/10.1158/1538-7445.MEL2014-A26
Published: 16 July 2015
View article titled, Abstract A26: Protein phosphatase 4 (PP4) as a potential therapeutic target gene for BRAF wild type melanoma
Journal Articles

Abstract 1321: Identification of markers of sensitivity and resistance to palbociclib (PD0332991) in melanoma

Erika M. von Euw, Dylan Conklin, Hong-Mei Rong, Ke-Wei Gong, Richard S. Finn, Dennis J. Slamon
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1321.
https://doi.org/10.1158/1538-7445.AM2014-1321
Published: 01 October 2014
View article titled, Abstract 1321: Identification of markers of sensitivity and resistance to palbociclib (PD0332991) in melanoma
Journal Articles

Abstract 2437: MEK162 (ARRY 438162), a MEK1/2 inhibitor, has activity in melanoma cells independent of BRAF and NRAS mutation status.

Erika M. Von Euw, Hong-Mei Rong, Neil O'Brien, Dylan Conklin, Veerauo Konkankit, Ke-Wei Gong, Angela Zubel, Ronald Linnartz, Richard Finn, Bartosz Chmielowski, Dennis Slamon
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2437.
https://doi.org/10.1158/1538-7445.AM2013-2437
Published: 15 April 2013
View article titled, Abstract 2437: MEK162 (ARRY 438162), a MEK1/2 inhibitor, has activity in melanoma cells independent of BRAF and NRAS mutation status.
Journal Articles

Abstract 2077A: MM141, a novel bispecific antibody co-inhibitor of IGF-1R and ErbB3, inhibits the proliferation of melanoma cells.

Erika M. Von Euw, Emily Pace, Karina Covarrubias, Abhi Jairam, Diana Chai, Veerauo Konkankit, Ke-Wei Gong, Bryan Johnson, Birgit Schoeberl, Alexey Lugovskoy, Finn Richard, Dennis Slamon
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2077A.
https://doi.org/10.1158/1538-7445.AM2013-2077A
Published: 15 April 2013
View article titled, Abstract 2077A: MM141, a novel bispecific antibody co-inhibitor of IGF-1R and ErbB3, inhibits the proliferation of melanoma cells.
Journal Articles

Abstract LB-257: Ganitumab (AMG 479), an anti IGF-1R antibody, inhibits the proliferation of melanoma cells

Erika M. Von Euw, Veerauo V. Konkankit, Ke-Wei Gong, Frank Calzone, Richard S. Finn, Bartosz Chmielowski, Dennis J. Slamon
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): LB-257.
https://doi.org/10.1158/1538-7445.AM2012-LB-257
Published: 15 April 2012
View article titled, Abstract LB-257: Ganitumab (AMG 479), an anti IGF-1R antibody, inhibits the proliferation of melanoma cells
Journal Articles

Abstract 4570: Functional analysis of gene expression profiling of primary and metastatic melanoma: Possible implications from BRAF mutant and wild-type cell lines

Richard Essner, Ke Wei Gong, Bartosz Chmielowski, Richard Finn, William D. Tap, Dennis Slamon
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4570.
https://doi.org/10.1158/1538-7445.AM2012-4570
Published: 15 April 2012
View article titled, Abstract 4570: Functional analysis of gene expression profiling of primary and metastatic melanoma: Possible implications from BRAF mutant and wild-type cell lines
Journal Articles

Isoform specific interaction between ING1 and 14-3-3

Wei Gong, Kalr T. Riabowol
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1207.
Published: 01 April 2004
View article titled, Isoform specific interaction between ING1 and 14-3-3